Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124638956 | 12463895 | 6 | F | 20130727 | 20160915 | 20160614 | 20160925 | EXP | PHJP2016JP015553 | SANDOZ | MOMOZANE T, INOUE M, MINAMI M, SHINTANI Y, FUNAKI S, KAWAMURA T ET AL.. VARICELLA ZOSTER VIRUS INFECTION AFTER LUNG TRANSPLANTATION. THE JOURNAL OF THE JAPANESE ASSOCIATION FOR CHEST SURGERY. 2016;30:410-6 | 62.69 | YR | M | Y | 0.00000 | 20160926 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124638956 | 12463895 | 1 | PS | NEORAL | CYCLOSPORINE | 1 | Oral | 200 NG/ML, UNK | 0 | CAPSULE | |||||||||
| 124638956 | 12463895 | 2 | SS | NEORAL | CYCLOSPORINE | 1 | 0 | CAPSULE | |||||||||||
| 124638956 | 12463895 | 3 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | 10 MG, QOD | 0 | 10 | MG | TABLET | |||||||
| 124638956 | 12463895 | 4 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | 0 | TABLET | |||||||||||
| 124638956 | 12463895 | 5 | SS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Oral | 2250 MG, QD | Y | 0 | 2250 | MG | CAPSULE | QD | |||||
| 124638956 | 12463895 | 6 | SS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Unknown | 1500 MG, QD | Y | 0 | 1500 | MG | CAPSULE | QD | |||||
| 124638956 | 12463895 | 7 | C | TAKEPRON | LANSOPRAZOLE | 1 | Oral | 30 MG, QD | U | 0 | 30 | MG | TABLET | QD | |||||
| 124638956 | 12463895 | 8 | C | HALIZON | AMPHOTERICIN B | 1 | Oral | 300 MG, TID | 0 | 300 | MG | SYRUP | TID | ||||||
| 124638956 | 12463895 | 9 | C | LASIX | FUROSEMIDE | 1 | Oral | 10 MG, BID | U | 0 | 10 | MG | TABLET | BID | |||||
| 124638956 | 12463895 | 10 | C | MAGLAX | MAGNESIUM OXIDE | 1 | Oral | 250 MG, BID | U | 0 | 250 | MG | TABLET | BID | |||||
| 124638956 | 12463895 | 11 | C | URALYT | POTASSIUM CITRATETRISODIUM CITRATE DIHYDRATE | 1 | Oral | 1 DF, TID | U | 0 | 1 | DF | TABLET | TID | |||||
| 124638956 | 12463895 | 12 | C | WARFARIN | WARFARIN | 1 | Oral | 2 MG, QD | 0 | 2 | MG | TABLET | QD | ||||||
| 124638956 | 12463895 | 13 | C | BAYASPIRIN | ASPIRIN | 1 | Oral | 100 MG, QD | 0 | 100 | MG | TABLET | QD | ||||||
| 124638956 | 12463895 | 14 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, QD | U | 0 | 5 | MG | TABLET | QD | |||||
| 124638956 | 12463895 | 15 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MG, QD | U | 0 | 75 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124638956 | 12463895 | 1 | Lung transplant |
| 124638956 | 12463895 | 2 | Immunosuppressant drug therapy |
| 124638956 | 12463895 | 3 | Lung transplant |
| 124638956 | 12463895 | 4 | Immunosuppressant drug therapy |
| 124638956 | 12463895 | 5 | Lung transplant |
| 124638956 | 12463895 | 6 | Immunosuppressant drug therapy |
| 124638956 | 12463895 | 7 | Product used for unknown indication |
| 124638956 | 12463895 | 8 | Infection prophylaxis |
| 124638956 | 12463895 | 9 | Chronic kidney disease |
| 124638956 | 12463895 | 10 | Constipation |
| 124638956 | 12463895 | 11 | Hyperuricaemia |
| 124638956 | 12463895 | 12 | Coronary angioplasty |
| 124638956 | 12463895 | 13 | Coronary angioplasty |
| 124638956 | 12463895 | 14 | Pulmonary arterial hypertension |
| 124638956 | 12463895 | 15 | Coronary angioplasty |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124638956 | 12463895 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124638956 | 12463895 | Abdominal pain upper | |
| 124638956 | 12463895 | Blister | |
| 124638956 | 12463895 | Hepatic function abnormal | |
| 124638956 | 12463895 | Oesophageal ulcer | |
| 124638956 | 12463895 | Product use issue | |
| 124638956 | 12463895 | Rash erythematous | |
| 124638956 | 12463895 | Rash generalised | |
| 124638956 | 12463895 | Rash vesicular | |
| 124638956 | 12463895 | Respiratory symptom | |
| 124638956 | 12463895 | Varicella zoster pneumonia | |
| 124638956 | 12463895 | Varicella zoster virus infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124638956 | 12463895 | 1 | 200812 | 0 | ||
| 124638956 | 12463895 | 3 | 200812 | 0 | ||
| 124638956 | 12463895 | 5 | 200812 | 0 | ||
| 124638956 | 12463895 | 8 | 200812 | 0 | ||
| 124638956 | 12463895 | 12 | 201305 | 0 | ||
| 124638956 | 12463895 | 13 | 201305 | 0 |